NGF activation of TrkA decreases N-myc expression via MAPK path leading to a decrease in neuroblastoma cell number

Oncogene

Volumn 23, Issue 8, 2004, Pages 1522-1530

  Woo, Chan Wook ^a   Lucarelli, Enrico ^a,b   Thiele, Carol J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

Cell cycle; E2F; MAPK; N myc; Neuroblastoma; NGF; p27; TrkA

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIN E; CYCLOHEXIMIDE; K 252A; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; PROTEIN P27; PROTEIN P75; TRANSCRIPTION FACTOR E2F; CARBAZOLE DERIVATIVE; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE; CYCLIN E DEPENDENT KINASE; CYCLIN E-DEPENDENT KINASE; DNA BINDING PROTEIN; ENZYME INHIBITOR; K 252; MAP3K1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 1; MYC PROTEIN; PROTEIN TYROSINE KINASE A; TRANSCRIPTION FACTOR;

ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NEUROBLASTOMA CELL; NORTHERN BLOTTING; ONCOGENE C MYB; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; CELL COUNT; CELL DIVISION; DRUG EFFECT; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; NEUROBLASTOMA; TIME; TUMOR CELL LINE;

CARBAZOLES; CELL COUNT; CELL CYCLE PROTEINS; CELL DIVISION; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASES; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; ENZYME ACTIVATION; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAP KINASE KINASE KINASE 1; MAP KINASE KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; NERVE GROWTH FACTOR; NEUROBLASTOMA; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTOR, TRKA; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 1542531898     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207267     Document Type: Article

References (59)

1. Adams MR, Sears R, Nuckolls F, Leone G and Nevins JR. (2000). Mol. Cell. Biol., 20, 3633-3639.
2. Amati B, Frank SR, Donjerkovic D and Taubert S. (2001). Biochim. Biophys. Acta, 1471, M135-M145.
3. Azar CG, Scavarda NJ, Reynolds CP and Brodeur M. (1990). Cell Growth Differ., 1, 421-428.
4. Beier R, Burgin A, Kiermaier A, Fero M, Karsunky H, Saffrich R, Moroy T, Ansorge W, Roberts J and Eilers M. (2000). EMBO J., 19, 5813-5823.
5. Berns K, Martins C, Dannenberg JH, Berns A, Riele Ht and Bernards R. (2000). Oncogene, 19, 4822-4827.
6. Billon N, van Grunsven LA and Rudkin BB. (1996). Oncogene, 13, 2047-2054.
7. Bogenmann E, Peterson S, Maekawa K and Matsushima H. (1998). Oncogene, 17, 2367-2376.
8. Borello MG, Bongarzone I, Pierotti MA, Luksch R, Gasparini M, Collini P, Pilotti S, Rizzetti MG, Mondellini P, De Bernardi B, Di Martino D, Garaventa A, Brisigotti M and Tonin GP. (1993). Int. J. Cancer, 54, 540-545.
9. Bulseco DA, Poluha W, Schonhoff CM, Daou MC, Condon PJ and Ross AH. (2001). J. Cell. Biochem., 81, 193-204.
10. Chambery D, Mohseni-Zadeh S, de Galle B and Babajko S. (1999). Cancer Res., 59, 2898-2902.
11. Ciccarone V, Spengler BA, Meyers MB, Biedler JL and Ross R. (1989). Cancer Res., 49, 219-225.
12. Dechant G. (2001). Cell Tissue Res., 305, 229-238.
13. Decker SJ. (1995). J. Biol. Chem., 270, 30841-30844.
14. Dobashi Y, Kudoh T, Matsumine A, Toyoshima K and Akiyama T. (1995). J. Biol. Chem., 270, 23031-23037.
15. Fan L, Iyer J, Zhu S, Frick KK, Wada RK, Eskenazi AE, Berg PE, Ikegaki N, Kennett RH and Frantz CN. (2001). Cancer Res., 61, 1073-1079.
16. Hartman DS and Hertel C. (1994). J. Neurochem., 63, 1261-1270.
17. Jain M, Arvanitis C, Chu K, Dewey W, Leonhardt E, Trinh M, Sundberg CD, Bishop JM and Felsher DW. (2002). Science, 297, 102-104.
18. Kao S, Jaiswal RK, Kolch W and Landreth GE. (2001). J. Biol. Chem., 276, 18169-18177.
19. Kihara-Negashi F, Yamamoto H, Suzuki M, Yamada T, Sakurai T, Tamura T and Oikawa T. (2001). Oncogene, 20, 6039-6047.
20. Kim B, Cheng HL, Margolis B and Feldman EL. (1998). J. Biol. Chem., 273, 34543-34550.
21. Kogner P, Barbany G, Dominici C, Castello MA, Raschella G and Persson H. (1993). Cancer Res., 53, 2044-2050.
22. Knudson Jr AG and Meadows AT. (1980). N. Engl. J. Med., 302, 1254-1256.
23. Lavenius E, Gestblom C, Johansson I, Nanberg E and Pahlman S. (1995). Cell Growth Differ., 6, 727-736.
24. Lucarelli E, Kaplan D and Thiele CJ. (1995). J. Biol. Chem., 270, 24725-24731.
25. Lutz W, Stohr M, Schurmann J, Wenzel A, Lohr A and Schwab M. (1996). Oncogene, 13, 803-812.
26. MacNicol MC and MacNicol AM. (1999). J. Biol. Chem., 274, 13193-13197.
27. Mansour SJ, Matten WT, Hermann AS, Candia JM, Rong S, Fukasawa K, Vande Woude GF and Ahn NG. (1994). Science, 265, 966-970.
28. Matsumoto K, Wada RK, Yamshiro JM, Kaplan DR and Thiele CJ. (1995). Cancer Res., 55, 1798-1806.
29. Matsuo T and Thiele CJ. (1998). Oncogene, 16, 3337-3343.
30. Matsushima H and Bogenmann E. (1993). Mol. Cell. Biol., 13, 7447-7456.
31. Miller FD and Kaplan DR. (2000). Curr. Opin. Neurobiol., 10, 381-391.
32. Misawa A, Hosoi H, Arimoto A, Shikata T, Akioka S, Matsumura T, Houghton PJ and Sawada T. (2000). Cancer Res., 60, 64-69.
33. Misawa A, Hosoi H, Tsuchuya K and Sugimoto T. (2003). Int. J. Cancer, 104, 233-237.
34. Nakagawara A, Nakagawara-Arima M, Scavarda NJ, Azar CG, Canto AB and Brodeur M. (1993). N. Engl. J. Med., 328, 847-854.
35. Nakamura M, Matsuo T, Stauffer J, Neckers L and Thiele CJ. (2003). Cell Death Differ., 10, 230-239.
36. Ong SH, Guy GR, Hadari YR, Laks S, Gotoh N, Sclessinger J and Lax I. (2000). Mol. Cell. Biol., 20, 979-989.
37. Persengiev SP, Kondova II and Kilpatrick DL. (1999). Mol. Cell. Biol., 19, 6048-6056.
38. Persengiev SP, Li J, Poulin ML and Kilpatrick DL. (2001). Oncogene, 20, 5124-5131.
39. Poluha W, Poluha DK, Chang B, Crosbie NE, Schonhoff CM, Kilpatrick DL and Ross AH. (1996). Mol. Cell. Biol., 16, 1335-1341.
40. Poluha W, Poluha DK and Ross AH. (1995). Oncogene, 10, 185-189.
41. Pumiglia KM and Decker SJ. (1997). Proc. Natl Acad. Sci. USA, 94, 448-452.
42. Reynolds CP, Biedler JL, Spengler BA, Reynolds DA, Ross RA, Frenkel EP and Smith RG. (1986). J. Natl. Cancer Inst., 76, 375-387.
43. Santoni-Rugiu E, Falck J, Mailand N, Bartek J and Lukas J. (2000). Mol. Cell. Biol., 20, 3497-3509.
44. Skolnik EY, Lee CH, Batzer A, Vincentini LM, Zhou M, Daly R, Myers Jr MG, Baker JM, Ullrich A, White MF and Schlessinger J. (1993). EMBO J., 12, 1929-1936.
45. Sherr CJ. (1993). Cell, 73, 1059-1065.
46. Strieder V and Lutz W. (2002). Cancer Lett., 180, 107-119.
47. Strieder V and Lutz W. (2003). J. Biol. Chem., 278, 2983-2989.
48. Suzuki T, Bogenmann E, Shimada H, Stram D and Seeger RC. (1993). J. Natl. Cancer Inst., 85, 337-384.
49. Thiele CJ, Deutsch LA and Israel MA. (1988). Oncogene, 3, 281-288.
50. Thiele CJ, Reynolds CP and Israel MA. (1985). Nature, 313, 404-406.
51. Tsygankova OM, Saavedra A, Rebhun JF, Quilliam LA and Meinkoth JL. (2001). Mol. Cell. Biol., 21, 1921-1929.
52. van Grunsven LA, Billon N, Savatier P, Thomas A, Urdiales JL and Rubkin BB. (1996). Oncogene, 12, 1347-1356.
53. Veenstra TD, Windebank AJ and Kumar R. (1997). Biochem. Biophys. Res. Commun., 235, 15-18.
54. Wada RK, Seeger RC, Reynolds P, Alloggiamento T, Yamashiro JM, Ruland C, Black AC and Rosenblatt JD. (1992). Oncogene, 7, 711-717.
55. Wittrock J, Schweizer P and Girgert R. (2002). Anticancer Res., 22, 4205-4209.
56. Wu C, Lai CF and Mobley WC. (2001). J. Neurosci., 21, 5406-5416.
57. Yang SH, Bumpass DC, Perkins ND and Sharrocks AD. (2002). Mol. Cell. Biol., 21, 5036-5046.
58. York RD, Yao H, Dillon T, Ellig CL, Eckert SP, McCleskey EW and Stork PJS. (1998). Nature, 392, 622-626.
59. Zhang X, Xing G and Saunders GF. (1999). Anticancer Res., 19, 1641-1648.